Jazz Pharmaceuticals (JAZZ) EVP Samantha Pearce Withholds 780 Shares for Taxes

What Happened Samantha Pearce, EVP and Chief Commercial Officer of Jazz Pharmaceuticals, had 780 shares withheld on 2026-08-05 to satisfy tax obligations arising from the vesting of previously granted restricted stock units. The withholding was reported at $261.62 per share for a total value of approximately $204,064. This was a tax-withholding disposition, not an open-market sale.

Key Details

• Transaction date and price: 2026-08-05 at $261.62 per share
• Shares withheld/disposed: 780 shares — total value ≈ $204,064
• Transaction code: F (shares withheld to satisfy tax withholding on vested awards)
• Footnote: F1 — shares withheld to satisfy tax obligations from vesting of RSUs
• Filing: Report filed 2026-08-07 (timely; within standard Form 4 reporting window)
• Shares owned after transaction: Not specified in the provided filing

Context

• This is a routine cashless withholding to cover taxes on vested restricted stock units, not a market sale; it reduces the insider’s share count but does not necessarily indicate a change in sentiment.
• For retail investors, tax-withholding dispositions are common following vesting events and should be distinguished from open-market sales or purchases.